Company intelligence / Profile preview

Goldcrest Capital

Dallas, Texas, United States

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Goldcrest Capital is an active Dallas-based venture capital firm focused on early-stage investments in technology sectors, including selective life sciences and biotech, but does not itself develop drugs, devices, or diagnostics.

Industry: Investors

Partnerships

They act as an investor rather than having corporate partnerships typical of biotech/pharma companies. However, Goldcrest has invested in several biotech/healthtech startups, e.g., Terray Therapeutics and Junevity.

Beyond the preview

Go deeper on Goldcrest Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Goldcrest Capital.

Explore the full profile